As shown in Fig. 3a, b, compare to the vehicle treatment, GLT8D2-shRNA plus CDDP treatment resulted in a significantly reduction in tumor growth and tumor weight compared with that in the control group. The gene discussed is GLT8D2; the disease is neoplasm.